Context Therapeutics Inc (CNTX) Company Profile & Statistics

Context Therapeutics Inc
CNTX
(Nasdaq - US)
N/A
1.87
+0.12 (+6.86%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
1.71
High
1.87
Low
1.68

About Context Therapeutics Inc

CEO

Martin Lehr

Headquarters

2001 market street, suite 3915 unit #15

philadelphia, pa 19103, united states

Auditor

CohnReznick LLP

Employees

Share Holders

Website

www.contexttherapeutics.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Context Therapeutics Inc. is a women's oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. Context Therapeutics Inc. is headquartered in Philadelphia, PA.

Context Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	N/A
Enterprise Value	N/A
Enterprise Value/EBITDA (ttm)	N/A
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.35
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-115.50%
Return on Invested Capital (ttm)	-131.81%
Return on Assets (ttm)	-97.04%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-25.06M
Net Income Avi to Common (ttm)	-23.96M
Diluted EPS (ttm)	-1.50

Share Statistics

Beta (5Y Monthly)	2.14
52-Week Change	287.97%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	15.97M
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	6.66%
% Held by Institutions	14.03%

Balance Sheet

Total Cash (mrq)	14.45M
Total Cash Per Share (mrq)	0.91
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.83%
Quick Ratio (mrq)	3.83%
Book Value Per Share (mrq)	0.74

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.32
Free Cash Flow (ytd)	-21.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Context Therapeutics Inc

Trade With A Regulated Broker